Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus
Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...
Saved in:
Published in: | Journal of Virology Vol. 83; no. 23; pp. 12473 - 12482 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Washington, DC
American Society for Microbiology
01-12-2009
American Society for Microbiology (ASM) |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
Spotlights in the Current Issue
JVI
About
JVI
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JVI
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0022-538X
Online ISSN:
1098-5514
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JVI
.asm.org, visit:
JVI
|
---|---|
AbstractList | Nearly all livers transplanted into hepatitis C virus (HCV)-positive patients become infected with HCV, and 10 to 25% of reinfected livers develop cirrhosis within 5 years. Neutralizing monoclonal antibody could be an effective therapy for the prevention of infection in a transplant setting. To pursue this treatment modality, we developed human monoclonal antibodies (HuMAbs) directed against the HCV E2 envelope glycoprotein and assessed the capacity of these HuMAbs to neutralize a broad panel of HCV genotypes. HuMAb antibodies were generated by immunizing transgenic mice containing human antibody genes (HuMAb mice; Medarex Inc.) with soluble E2 envelope glycoprotein derived from a genotype 1a virus (H77). Two HuMAbs, HCV1 and 95-2, were selected for further study based on initial cross-reactivity with soluble E2 glycoproteins derived from genotypes 1a and 1b, as well as neutralization of lentivirus pseudotyped with HCV 1a and 1b envelope glycoproteins. Additionally, HuMAbs HCV1 and 95-2 potently neutralized pseudoviruses from all genotypes tested (1a, 1b, 2b, 3a, and 4a). Epitope mapping with mammalian and bacterially expressed proteins, as well as synthetic peptides, revealed that HuMAbs HCV1 and 95-2 recognize a highly conserved linear epitope spanning amino acids 412 to 423 of the E2 glycoprotein. The capacity to recognize and neutralize a broad range of genotypes, the highly conserved E2 epitope, and the fully human nature of the antibodies make HuMAbs HCV1 and 95-2 excellent candidates for treatment of HCV-positive individuals undergoing liver transplantation. Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology. For an alternate route to JVI .asm.org, visit: JVI |
Author | Robert W. Finberg Gregory J. Babcock Naomi K. Boatright Frantisek Sandor Susan E. Sloan Teresa J. Broering Kerry A. Garrity William D. Thomas Jr Donna M. Ambrosino Gyongyi Szabo |
AuthorAffiliation | MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, 1 Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 2 |
AuthorAffiliation_xml | – name: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, 1 Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 2 |
Author_xml | – sequence: 1 givenname: Teresa J surname: BROERING fullname: BROERING, Teresa J organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 2 givenname: Kerry A surname: GARRITY fullname: GARRITY, Kerry A organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 3 givenname: Naomi K surname: BOATRIGHT fullname: BOATRIGHT, Naomi K organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 4 givenname: Susan E surname: SLOAN fullname: SLOAN, Susan E organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 5 givenname: Frantisek surname: SANDOR fullname: SANDOR, Frantisek organization: Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States – sequence: 6 givenname: William D surname: THOMAS fullname: THOMAS, William D organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 7 givenname: Gyongyi surname: SZABO fullname: SZABO, Gyongyi organization: Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States – sequence: 8 givenname: Robert W surname: FINBERG fullname: FINBERG, Robert W organization: Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States – sequence: 9 givenname: Donna M surname: AMBROSINO fullname: AMBROSINO, Donna M organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States – sequence: 10 givenname: Gregory J surname: BABCOCK fullname: BABCOCK, Gregory J organization: MassBiologics, University of Massachusetts Medical School, Boston, Massachusetts, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22135970$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19759151$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1uEzEURkeoiKaFHWtkCSE2TPHPzNjeVCppaIIKbKBiZ93x2ImriR3smVTpo_C0mCYqsLJkH33fvT4nxZEP3hTFS4LPCKHi_aebxRkmhIkSyyfFhGApyrom1VExwZjSsmbix3FxktItxqSqmupZcUwkryWpyaT4teiMH5x1GgYXPALfoekKIujBRHe_vwwWfYgBun6HvphxiNC7e-eXaD6uwaPPwQfdBw89ushRbeicSejSRZMzOgRLcD4NaFgZNKNo5remDxuDrvqdDpsYBuMeGuZmk9sGl9AU3bg4pufFUwt9Mi8O52nx_ePs23ReXn-9WkwvrktdYz6UBgS2WFLZWoZtBcJWDetabggRYATn0jat1Q0mHGtoWwqtBExwR4XEbc3ZaXG-z92M7dp0Ov9H3lBtoltD3KkATv3_4t1KLcNWUS4a3jQ54O0hIIafo0mDWrukTd-DN2FMijNGGCGyzuS7PaljSCka-9hCsPpjU2Wb6sGmwjLjr_6d7C980JeBNwcAkobeRvDapUeOUsJqyXHmXu-5lVuu7rIZBWmtbrdOCaYoU4RWecjfLNa5OA |
CitedBy_id | crossref_primary_10_1126_science_1225416 crossref_primary_10_1146_annurev_immunol_032712_095916 crossref_primary_10_1016_j_coviro_2016_09_004 crossref_primary_10_1080_07391102_2023_2212777 crossref_primary_10_1155_2021_3108157 crossref_primary_10_1186_1755_8794_8_S4_S6 crossref_primary_10_1099_jgv_0_000493 crossref_primary_10_1002_hep_25827 crossref_primary_10_1016_j_antiviral_2014_02_013 crossref_primary_10_1016_j_jhep_2024_04_004 crossref_primary_10_3390_v3112280 crossref_primary_10_1111_imm_12323 crossref_primary_10_1016_j_jim_2013_11_005 crossref_primary_10_1016_j_vaccine_2011_02_083 crossref_primary_10_1053_j_gastro_2010_05_073 crossref_primary_10_1073_pnas_2112008119 crossref_primary_10_4254_wjh_v7_i1_53 crossref_primary_10_1016_j_antiviral_2010_07_007 crossref_primary_10_4254_wjh_v7_i22_2369 crossref_primary_10_1016_j_meegid_2017_01_006 crossref_primary_10_1089_vim_2016_0123 crossref_primary_10_1002_hep_28705 crossref_primary_10_1002_hep_28428 crossref_primary_10_1128_JVI_01403_18 crossref_primary_10_3389_fimmu_2022_910367 crossref_primary_10_1128_JVI_02700_15 crossref_primary_10_1371_journal_ppat_1006235 crossref_primary_10_1128_JVI_01939_12 crossref_primary_10_1053_j_gastro_2018_08_060 crossref_primary_10_1371_journal_ppat_1004297 crossref_primary_10_1128_jvi_00576_24 crossref_primary_10_1111_cei_12962 crossref_primary_10_1111_vox_12301 crossref_primary_10_3389_fmicb_2014_00329 crossref_primary_10_1093_infdis_jiw151 crossref_primary_10_1172_JCI160058 crossref_primary_10_3390_v16050803 crossref_primary_10_1128_microbiolspec_AID_0026_2014 crossref_primary_10_3390_v4091731 crossref_primary_10_1371_journal_pone_0274283 crossref_primary_10_1007_s10989_019_09972_7 crossref_primary_10_1016_j_coviro_2021_07_003 crossref_primary_10_3109_00365521_2011_579155 crossref_primary_10_1016_j_antiviral_2012_07_013 crossref_primary_10_1016_j_tim_2018_04_002 crossref_primary_10_1016_j_jmb_2013_02_025 crossref_primary_10_1155_2013_450963 crossref_primary_10_1128_JVI_01584_14 crossref_primary_10_1128_spectrum_02546_22 crossref_primary_10_1186_s12936_015_0577_7 crossref_primary_10_1016_j_pharmthera_2022_108233 crossref_primary_10_1016_j_coviro_2015_04_001 crossref_primary_10_1128_JVI_02397_15 crossref_primary_10_1099_vir_0_035956_0 crossref_primary_10_1016_j_isci_2023_106421 crossref_primary_10_1155_2013_632893 crossref_primary_10_3389_fmicb_2017_02692 crossref_primary_10_1038_s41541_020_00269_1 crossref_primary_10_1371_journal_pone_0061210 crossref_primary_10_1016_j_antiviral_2022_105266 crossref_primary_10_1371_journal_ppat_1006735 crossref_primary_10_1111_jvh_12632 crossref_primary_10_1128_JVI_02066_17 crossref_primary_10_2217_fmb_11_9 crossref_primary_10_1371_journal_ppat_1002653 crossref_primary_10_1002_lt_24344 crossref_primary_10_1016_j_immuni_2024_03_001 crossref_primary_10_1371_journal_ppat_1006214 crossref_primary_10_3389_fimmu_2018_01470 crossref_primary_10_1101_cshperspect_a036962 crossref_primary_10_2217_fvl_12_47 crossref_primary_10_1128_JVI_01732_14 crossref_primary_10_1111_jvh_12094 crossref_primary_10_3390_v3112127 crossref_primary_10_1073_pnas_2015149118 crossref_primary_10_1128_JVI_02052_12 crossref_primary_10_1002_hep_27013 crossref_primary_10_3389_fmicb_2017_02163 crossref_primary_10_1128_JVI_01941_12 crossref_primary_10_1016_j_virol_2015_03_014 crossref_primary_10_1093_ve_vead068 crossref_primary_10_1099_jgv_0_001378 crossref_primary_10_1128_JVI_02190_14 crossref_primary_10_1182_blood_2012_06_432153 crossref_primary_10_1053_j_gastro_2021_10_005 crossref_primary_10_3390_v13050833 crossref_primary_10_1371_journal_ppat_1004424 crossref_primary_10_1073_pnas_1614942113 crossref_primary_10_1371_journal_pcbi_1008421 crossref_primary_10_1016_j_jhep_2010_10_014 crossref_primary_10_1089_vim_2017_0182 crossref_primary_10_3390_v13050837 crossref_primary_10_1007_s12250_010_3134_0 crossref_primary_10_1073_pnas_1114927109 crossref_primary_10_1074_jbc_M115_643528 crossref_primary_10_1172_JCI78794 crossref_primary_10_1371_journal_pone_0055874 crossref_primary_10_3390_v13060983 crossref_primary_10_1074_jbc_RA120_013015 crossref_primary_10_2139_ssrn_4022365 crossref_primary_10_3390_vaccines9030291 crossref_primary_10_1073_pnas_1802378115 crossref_primary_10_1073_pnas_1202924109 crossref_primary_10_1016_j_celrep_2022_110859 crossref_primary_10_1016_j_vaccine_2019_04_071 crossref_primary_10_1016_j_virol_2019_07_026 crossref_primary_10_1186_1479_5876_9_194 crossref_primary_10_1128_JVI_02837_15 crossref_primary_10_3390_v13061027 crossref_primary_10_3390_v7072809 crossref_primary_10_4254_wjh_v13_i10_1234 crossref_primary_10_1128_JVI_01032_17 crossref_primary_10_3389_fimmu_2019_01145 crossref_primary_10_1038_s41598_018_24762_9 crossref_primary_10_1080_14760584_2016_1194759 crossref_primary_10_1128_JVI_01668_16 crossref_primary_10_1371_journal_pone_0126397 crossref_primary_10_1128_JVI_02070_15 crossref_primary_10_1586_egh_09_74 crossref_primary_10_1128_JVI_02133_17 crossref_primary_10_1002_hep_24171 crossref_primary_10_1371_journal_pone_0256816 crossref_primary_10_1016_j_idc_2011_07_006 crossref_primary_10_1128_JVI_02153_09 crossref_primary_10_3389_fimmu_2018_01315 crossref_primary_10_1016_j_isci_2021_103569 crossref_primary_10_1371_journal_pone_0100325 crossref_primary_10_1586_egh_12_72 crossref_primary_10_1126_science_1243876 crossref_primary_10_1128_JVI_00586_11 crossref_primary_10_1038_s41423_020_0403_1 crossref_primary_10_1371_journal_ppat_1001086 crossref_primary_10_3390_v15051151 crossref_primary_10_1016_j_jcis_2019_03_022 crossref_primary_10_3390_v3101909 crossref_primary_10_1111_ajt_12083 |
Cites_doi | 10.1128/JVI.01872-07 10.1002/hep.20906 10.1073/pnas.0501275102 10.1016/j.vaccine.2006.12.031 10.1053/jlts.2002.35852 10.1099/0022-1317-82-11-2589 10.1002/hep.21162 10.1099/vir.0.83065-0 10.1006/viro.1995.1016 10.1002/hep.21088 10.1074/jbc.M411600200 10.1128/IAI.00982-06 10.1128/JVI.01986-07 10.1128/JVI.78.13.7257-7263.2004 10.1126/science.277.5325.570 10.1128/JVI.74.22.10407-10416.2000 10.1128/JVI.75.20.9986-9990.2001 10.1128/JVI.79.17.11095-11104.2005 10.1006/viro.1998.9202 10.1073/pnas.0809879105 10.1128/jvi.69.11.6705-6711.1995 10.1038/nm1698 10.1006/viro.2002.1463 10.1099/0022-1317-81-10-2451 10.1073/pnas.0705522104 10.1038/nature07684 10.1016/S0264-410X(00)00534-X 10.1099/vir.0.83386-0 10.1073/pnas.0832180100 10.1016/0016-5085(92)91129-R 10.1053/j.gastro.2006.12.008 10.1038/nature05654 10.1128/JVI.73.8.6235-6244.1999 10.1084/jem.20021756 10.1093/emboj/cdf529 10.1126/science.282.5390.938 10.1128/JVI.78.9.4552-4560.2004 10.1128/JVI.00271-06 10.1074/jbc.R700024200 10.1074/jbc.M705358200 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS Copyright © 2009, American Society for Microbiology 2009 |
Copyright_xml | – notice: 2009 INIST-CNRS – notice: Copyright © 2009, American Society for Microbiology 2009 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1128/JVI.01138-09 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1098-5514 |
EndPage | 12482 |
ExternalDocumentID | 10_1128_JVI_01138_09 19759151 22135970 jvi_83_23_12473 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ 08R 0R~ 18M 29L 2WC 39C 3O- 4.4 41~ 53G 5GY 5RE 5VS 6TJ 85S AAUGY AAYJJ ABPPZ ABPTK ACGFO ACNCT ADBBV AENEX AFDAS AFFNX AI. ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW C1A CS3 D0S DIK E3Z EBS EJD F20 F5P FRP GX1 H13 HYE HZ~ IH2 IQODW KQ8 MVM N9A O9- OHT OK1 P2P RHF RHI RNS RPM RSF TR2 UCJ UPT VH1 W2D W8F WH7 WOQ X7M XFK Y6R YQT ZA5 ZGI ZXP ~02 ~KM AGVNZ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c507t-ea80f0929bf30f4a8f463db7e118ae8779f6bfc60170cabb2ab9a010d2890b573 |
IEDL.DBID | RPM |
ISSN | 0022-538X |
IngestDate | Tue Sep 17 21:26:28 EDT 2024 Fri Oct 25 12:03:51 EDT 2024 Thu Nov 21 22:03:02 EST 2024 Sat Sep 28 07:48:36 EDT 2024 Sun Oct 22 16:05:00 EDT 2023 Wed May 18 15:25:42 EDT 2016 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 23 |
Keywords | Virus Human Envelope virus Glycoprotein Identification Monoclonal antibody Flaviviridae Hepatitis C virus Hepacivirus Neutralizing antibody |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c507t-ea80f0929bf30f4a8f463db7e118ae8779f6bfc60170cabb2ab9a010d2890b573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://europepmc.org/articles/pmc2786766?pdf=render |
PMID | 19759151 |
PQID | 733131195 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | crossref_primary_10_1128_JVI_01138_09 pubmedcentral_primary_oai_pubmedcentral_nih_gov_2786766 proquest_miscellaneous_733131195 pubmed_primary_19759151 pascalfrancis_primary_22135970 highwire_asm_jvi_83_23_12473 |
PublicationCentury | 2000 |
PublicationDate | 2009-12-01 |
PublicationDateYYYYMMDD | 2009-12-01 |
PublicationDate_xml | – month: 12 year: 2009 text: 2009-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States |
PublicationTitle | Journal of Virology |
PublicationTitleAlternate | J Virol |
PublicationYear | 2009 |
Publisher | American Society for Microbiology American Society for Microbiology (ASM) |
Publisher_xml | – name: American Society for Microbiology – name: American Society for Microbiology (ASM) |
References | 16496330 - Hepatology. 2006 Mar;43(3):592-601 9228008 - Science. 1997 Jul 25;277(5325):570-4 11602769 - J Gen Virol. 2001 Nov;82(Pt 11):2589-95 15767578 - Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4560-5 12761383 - Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7271-6 12362294 - Liver Transpl. 2002 Oct;8(10 Suppl 1):S19-27 17881349 - J Biol Chem. 2008 Feb 15;283(7):3689-93 17240489 - Vaccine. 2007 Apr 12;25(15):2800-10 17911260 - Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16269-74 11559832 - J Virol. 2001 Oct;75(20):9986-90 7531918 - Virology. 1995 Feb 1;206(2):935-44 17325668 - Nature. 2007 Apr 12;446(7137):801-5 18272755 - J Gen Virol. 2008 Mar;89(Pt 3):653-9 10993933 - J Gen Virol. 2000 Oct;81(Pt 10):2451-9 17977972 - J Virol. 2008 Jan;82(2):966-73 19052239 - Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19450-5 16966409 - Infect Immun. 2006 Nov;74(11):6339-47 11044085 - J Virol. 2000 Nov;74(22):10407-16 9794763 - Science. 1998 Oct 30;282(5390):938-41 19182773 - Nature. 2009 Feb 12;457(7231):882-6 16103160 - J Virol. 2005 Sep;79(17):11095-104 16628639 - Hepatology. 2006 May;43(5):1157-65 11282207 - Vaccine. 2001 Apr 6;19(20-22):2955-64 15194801 - J Virol. 2004 Jul;78(13):7257-63 1377143 - Gastroenterology. 1992 Jul;103(1):317-22 16912317 - J Virol. 2006 Sep;80(17):8695-704 18064037 - Nat Med. 2008 Jan;14(1):25-7 15632171 - J Biol Chem. 2005 Mar 4;280(9):7793-9 9740774 - Virology. 1998 Sep 15;249(1):32-41 15078936 - J Virol. 2004 May;78(9):4552-60 16250048 - Hepatology. 2005 Nov;42(5):1055-62 17258731 - Gastroenterology. 2007 Feb;132(2):667-78 7474080 - J Virol. 1995 Nov;69(11):6705-11 10400713 - J Virol. 1999 Aug;73(8):6235-44 17947521 - J Gen Virol. 2007 Nov;88(Pt 11):2991-3001 12093180 - Virology. 2002 Jun 20;298(1):124-32 17989176 - J Virol. 2008 Jan;82(2):1047-52 12356718 - EMBO J. 2002 Oct 1;21(19):5017-25 17761674 - J Biol Chem. 2007 Nov 2;282(44):32357-69 12615904 - J Exp Med. 2003 Mar 3;197(5):633-42 e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 |
References_xml | – ident: e_1_3_2_23_2 doi: 10.1128/JVI.01872-07 – ident: e_1_3_2_32_2 doi: 10.1002/hep.20906 – ident: e_1_3_2_22_2 doi: 10.1073/pnas.0501275102 – ident: e_1_3_2_34_2 doi: 10.1016/j.vaccine.2006.12.031 – ident: e_1_3_2_10_2 doi: 10.1053/jlts.2002.35852 – ident: e_1_3_2_24_2 doi: 10.1099/0022-1317-82-11-2589 – ident: e_1_3_2_20_2 doi: 10.1002/hep.21162 – ident: e_1_3_2_35_2 doi: 10.1099/vir.0.83065-0 – ident: e_1_3_2_7_2 doi: 10.1006/viro.1995.1016 – ident: e_1_3_2_36_2 doi: 10.1002/hep.21088 – ident: e_1_3_2_38_2 doi: 10.1074/jbc.M411600200 – ident: e_1_3_2_3_2 doi: 10.1128/IAI.00982-06 – ident: e_1_3_2_28_2 doi: 10.1128/JVI.01986-07 – ident: e_1_3_2_18_2 doi: 10.1128/JVI.78.13.7257-7263.2004 – ident: e_1_3_2_19_2 doi: 10.1126/science.277.5325.570 – ident: e_1_3_2_14_2 doi: 10.1128/JVI.74.22.10407-10416.2000 – ident: e_1_3_2_6_2 doi: 10.1128/JVI.75.20.9986-9990.2001 – ident: e_1_3_2_25_2 doi: 10.1128/JVI.79.17.11095-11104.2005 – ident: e_1_3_2_13_2 doi: 10.1006/viro.1998.9202 – ident: e_1_3_2_12_2 doi: 10.1073/pnas.0809879105 – ident: e_1_3_2_15_2 doi: 10.1128/jvi.69.11.6705-6711.1995 – ident: e_1_3_2_21_2 doi: 10.1038/nm1698 – ident: e_1_3_2_37_2 doi: 10.1006/viro.2002.1463 – ident: e_1_3_2_2_2 doi: 10.1099/0022-1317-81-10-2451 – ident: e_1_3_2_17_2 doi: 10.1073/pnas.0705522104 – ident: e_1_3_2_30_2 doi: 10.1038/nature07684 – ident: e_1_3_2_33_2 doi: 10.1016/S0264-410X(00)00534-X – ident: e_1_3_2_26_2 doi: 10.1099/vir.0.83386-0 – ident: e_1_3_2_16_2 doi: 10.1073/pnas.0832180100 – ident: e_1_3_2_41_2 doi: 10.1016/0016-5085(92)91129-R – ident: e_1_3_2_40_2 doi: 10.1053/j.gastro.2006.12.008 – ident: e_1_3_2_9_2 doi: 10.1038/nature05654 – ident: e_1_3_2_11_2 doi: 10.1128/JVI.73.8.6235-6244.1999 – ident: e_1_3_2_5_2 doi: 10.1084/jem.20021756 – ident: e_1_3_2_31_2 doi: 10.1093/emboj/cdf529 – ident: e_1_3_2_29_2 doi: 10.1126/science.282.5390.938 – ident: e_1_3_2_4_2 doi: 10.1128/JVI.78.9.4552-4560.2004 – ident: e_1_3_2_27_2 doi: 10.1128/JVI.00271-06 – ident: e_1_3_2_39_2 doi: 10.1074/jbc.R700024200 – ident: e_1_3_2_8_2 doi: 10.1074/jbc.M705358200 |
SSID | ssj0014464 |
Score | 2.4298503 |
Snippet | Article Usage Stats
Services
JVI
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley... Nearly all livers transplanted into hepatitis C virus (HCV)-positive patients become infected with HCV, and 10 to 25% of reinfected livers develop cirrhosis... |
SourceID | pubmedcentral proquest crossref pubmed pascalfrancis highwire |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 12473 |
SubjectTerms | Amino Acid Sequence Animals Antibodies, Monoclonal - immunology Antibodies, Monoclonal - isolation & purification Biological and medical sciences Conserved Sequence Epitope Mapping Epitopes, B-Lymphocyte - genetics Epitopes, B-Lymphocyte - immunology Fundamental and applied biological sciences. Psychology Hepacivirus - immunology Hepatitis C Antibodies - immunology Hepatitis C Antibodies - isolation & purification Humans Mice Mice, Transgenic Microbiology Miscellaneous Molecular Sequence Data Neutralization Tests Vaccines and Antiviral Agents Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Viral Envelope Proteins - immunology Virology |
Title | Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus |
URI | http://jvi.asm.org/content/83/23/12473.abstract https://www.ncbi.nlm.nih.gov/pubmed/19759151 https://search.proquest.com/docview/733131195 https://pubmed.ncbi.nlm.nih.gov/PMC2786766 |
Volume | 83 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB3RlZC4IL4JLCsf4Jg2sd04OaLSZUFihQSs9mb5E7Jqk9WmRSo_hV_L2EkKRZw4J7GjzEz8xvP8BuBlVVghLM_TADZSXros1ULzlFaWeetYzkxsYvtJnF-Wb5ZBJmc-noWJpH2j62mzWk-b-lvkVl6vzWzkic0-flhQURaiKGYTmCA2HFP0oXSA-Q0fJcIxmi9HtjstZ-8v3k3Rn1ko-Ee1UDGv8nl-uCSNMsGBJak6_FC-73DxLwj6N5Pyj6Xp9B7cHTAled2_-3245ZoHcLvvMrl7CD_7w7h-2J0jqrFksddp7o9hktYTzMiVXe3IudvG7Y8fuKqRuMlPMPJbs2rjLDiUbgP3kPS_S2eJ-qpqhJkEwSRZUrJsIhHJkbernWmjEkQdZzhzgb-9qTuyIBf1zbZ7BF9Ol58XZ-nQkiE1aMtN6lSZ-QwhlfYs81yVnhdRoRnzFOVKISpfaG-KoMpjlNZU6UphymdDPVPPBXsMR03buKdAlEfEbATiMa640lwh9LDMcO2YqTzNE3g1WkVe98obMmYstJRoSBkNKbMqgePRZFJ1a3n1vZYlk5RJhC6CJXByYMb9WJTmDLOpLAEy2lViaIV6iWpcu-1kaGfJgiReAk96M_9-kcF1EhAHDrC_Iah2H15BZ47q3YPzPvvvJ5_DHTo0scjyYzja3GzdC5h0dnsSI-EXipwQng |
link.rule.ids | 230,315,729,782,786,887,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVoEYIN70egFC9gmZnE9sTJEg1TptCOkChVd5afEDSTVM0EafgUvpZrJxkYxKpr5-3j-Fzf43MRel1khnPD0tiTjZjlNokVVywmhaHOWJpSHYrYfuaLi_zdzNvkTIa9MEG0r1U5qparUVV-C9rKy5UeDzqx8afTKeF5xrNsvIduwnhNkiFI75MHEOGwwSQc2i8GvTvJxx_Oj0eAaOpT_sEvlE-KdJLuTkqDUbDXScoGPpXralz8j4T-q6X8a3I6unfN17qP7vZsFL_tmh-gG7Z6iG519Sk3j9Cvbhuv69f1sKwMnm4dnrsNnLh2GGJ5aZYbvLBtWDj5CfMhDukBDP-MWi_rcBe4lKq9ahF3P1prsPwqSyCoGGgonhE8q4KEyeL3y42ug4dEGe4wt175vS4bPMXn5VXbPEZfjmZn03ncF3OINaBgHVuZJy4BMqYcTRyTuWNZ8HaGCEfanPPCZcrpzPv5aKkUkaqQECwanwlVE06foP2qruwzhKUDrq05MDkmmVRMAmkxVDNlqS4cSSP0ZuhNcdl5dogQ65BcAABEAIBIiggdDF0tZLMS33-UIqeCUAGkh9MIHe50__ZahKQU4rAkQnjAg4BB6TMtsrJ12whfCJN6M70IPe3g8edBeshFiO8AZ3uA9_vebQG8BN_vHh_Pr33mK3R7fnZ6Ik6OFx9foDukL4WRpAdof33V2pdorzHtYRhNvwHhriYw |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFLVoEYhNeRYCpXgBy0wSOxMnSzSdoeUxqgRU3Vl-QtBMMmomlYZP4Wu5dpKBQaxg7cR5Hcfn-h6fi9DLItOM6TQJHdkI09zEoWQyDUmhqdWGJlT5IrYf2fwyP5k6m5xtqS8v2leyHFWL5agqv3pt5WqpokEnFp1_mBCWZyzLopW20R66CWM2JkOg3icQIMpJB6NwaL8cNO8kj95enI0A1dSl_b1nKBsXyTjZnZgGs2CnlRQNvC7b1bn4GxH9U0_52wQ1u_sfj3YPHfSsFL_uDrmPbpjqAbrV1ancPEQ_uu28tl_fw6LSeLJ1eu42cuLaYojphV5s8Ny0fgHlO8yL2KcJMPw7arWo_VWgK1k79SLufrhGY_FFlEBUMdBRPCV4Wnkpk8FvFhtVey-J0l_h1DgF-Lps8ARflFdt8wh9nk0_TU7DvqhDqAAN69CIPLYxkDJpaWxTkds08x7PEOkIkzNW2ExalTlfHyWkJEIWAoJG7TKicszoIdqv6so8QVhY4NyKAaNLRSpkKoC8aKpSaagqLEkC9Gr4onzVeXdwH_OQnAMIuAcBj4sAHQ2fm4tmyb9dlzynnFAO5IfRAB3vQGDbFyEJhXgsDhAeMMFhcLqMi6hM3TbcFcSkzlQvQI87iPy6kR52AWI74Nke4Hy_d1sAM97_u8fI038-8wW6fX4y4-_P5u-eoTukr4gRJ0dof33Vmudor9HtsR9QPwH-LSiw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+characterization+of+broadly+neutralizing+human+monoclonal+antibodies+directed+against+the+E2+envelope+glycoprotein+of+hepatitis+C+virus&rft.jtitle=Journal+of+virology&rft.au=Broering%2C+Teresa+J&rft.au=Garrity%2C+Kerry+A&rft.au=Boatright%2C+Naomi+K&rft.au=Sloan%2C+Susan+E&rft.date=2009-12-01&rft.eissn=1098-5514&rft.volume=83&rft.issue=23&rft.spage=12473&rft.epage=12482&rft_id=info:doi/10.1128%2FJVI.01138-09&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |